Leebeek FWG - Search Results

1

A Novel, Enriched Population Pharmacokinetic Model for Recombinant Factor VIII-Fc Fusion Protein Concentrate in Hemophilia A Patients.

Bukkems LH, Heijdra JM, Mathias M, Collins PW, Hay CRM, Tait RC, Mangles S, Myers B, Evans G, Bailiff B, Curry N, Payne J, Austin S, Goedhart TMHJ, Leebeek FWG, Meijer K, Fijnvandraat K, Chowdary P, Mathôt RAA, Cnossen MH; for UK-EHL Outcomes Registry OPTI-CLOT Collaboration. Bukkems LH, et al. Among authors: leebeek fwg. Thromb Haemost. 2020 May;120(5):747-757. doi: 10.1055/s-0040-1709522. Epub 2020 May 5. Thromb Haemost. 2020. PMID: 32369846

2

Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation.

Lisman T, Leebeek FW, Meijer K, Van Der Meer J, Nieuwenhuis HK, De Groot PG. Lisman T, et al. Hepatology. 2002 Mar;35(3):616-21. doi: 10.1053/jhep.2002.31771. Hepatology. 2002. PMID: 11870375

3

In vitro studies, pharmacokinetic studies and clinical use of a high purity double virus inactivated FVIII/VWF concentrate (Immunate) in the treatment of von Willebrand disease.

Ver Elst KM, van Vliet HD, Kappers-Klunne MC, Leebeek FW. Ver Elst KM, et al. Thromb Haemost. 2004 Jul;92(1):67-74. doi: 10.1160/TH04-02-0107. Thromb Haemost. 2004. PMID: 15213847

4

Variation in fibrinogen FGG and FGA genes and risk of stroke: the Rotterdam Study.

Cheung EY, Bos MJ, Leebeek FW, Koudstaal PJ, Hofman A, de Maat MP, Breteler MM. Cheung EY, et al. Thromb Haemost. 2008 Aug;100(2):308-13. Thromb Haemost. 2008. PMID: 18690352

5

PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.

van Vliet HH, Kappers-Klunne MC, Leebeek FW, Michiels JJ. van Vliet HH, et al. Thromb Haemost. 2008 Sep;100(3):462-8. Thromb Haemost. 2008. PMID: 18766263

6

Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma.

Auwerda JJ, Yuana Y, Osanto S, de Maat MP, Sonneveld P, Bertina RM, Leebeek FW. Auwerda JJ, et al. Thromb Haemost. 2011 Jan;105(1):14-20. doi: 10.1160/TH10-03-0187. Epub 2010 Nov 5. Thromb Haemost. 2011. PMID: 21057704 Clinical Trial.

7

The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary intervention.

van Loon JE, de Jaegere PP, Ulrichts H, van Vliet HH, de Maat MP, de Groot PG, Simoons ML, Leebeek FW. van Loon JE, et al. Thromb Haemost. 2011 Jul;106(1):165-71. doi: 10.1160/TH10-12-0804. Epub 2011 Jun 9. Thromb Haemost. 2011. PMID: 21655675

8

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Collins P, Baudo F, Knoebl P, Lévesque H, Nemes L, Pellegrini F, Marco P, Tengborn L, Huth-Kühne A; EACH2 registry collaborators. Collins P, et al. Blood. 2012 Jul 5;120(1):47-55. doi: 10.1182/blood-2012-02-409185. Epub 2012 Apr 18. Blood. 2012. PMID: 22517903 Free PMC article.

9

Inhibitor incidence after intensive FVIII replacement for surgery in mild and moderate haemophilia A: a prospective national study in the Netherlands.

Eckhardt CL, Mauser-Bunschoten EP, Peters M, Leebeek FW, van der Meer FJ, Fijnvandraat K. Eckhardt CL, et al. Br J Haematol. 2012 Jun;157(6):747-52. doi: 10.1111/j.1365-2141.2012.09119.x. Epub 2012 Apr 26. Br J Haematol. 2012. PMID: 22533635 Free article. Clinical Trial.

10

Diagnosis and management of haemophilia.

Fijnvandraat K, Cnossen MH, Leebeek FW, Peters M. Fijnvandraat K, et al. BMJ. 2012 May 2;344:e2707. doi: 10.1136/bmj.e2707. BMJ. 2012. PMID: 22551712 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

382 results

Search Page